The combination of EGFR-CAR NK-92 cells with oHSV-1 resulted in more efficient killing of breast cancer tumor cells engrafted into the brain compared to monotherapies and significantly improved survival of mice bearing breast cancer tumor cells in the brain [116]. This evidence concerns the gene EGFR and neoplasm.